Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00763698 · ClinicalTrials.gov registry record · NA
Safety and Efficacy Study of the QuickFlex Micro Model 1258T Left Heart Pacing Lead
A NA study, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 86
- Enrollment target
NCT00763698 is a NA study that has completed, run by Abbott Medical Devices. The registered enrollment target is 86 participants.
The verdict
NCT00763698, a NA study, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
Study Summary
This is a prospective, multi-center non-randomized clinical study to evaluate the safety and efficacy of the QuickFlex Micro Model 1258T left ventricular lead in a heart failure patient population. The study will be conducted at a maximum of 20 investigational centers located in the United States and a total of 68 patients will be enrolled.
Interventions
- DEVICE QuickFlex Micro Model 1258T Left Heart Lead
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2008-10 |
| Est. Completion | 2010-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00763698
The ClinicalTrials.gov registry entry for NCT00763698 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 86 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which QuickFlex Micro Model 1258T Left Heart Lead is the first listed.
NCT00763698 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00763698 about?
NCT00763698 is a clinical study titled "Safety and Efficacy Study of the QuickFlex Micro Model 1258T Left Heart Pacing Lead". This is a prospective, multi-center non-randomized clinical study to evaluate the safety and efficacy of the QuickFlex Micro Model 1258T left ventricular lead in a heart failure patient population. The study will be conducted at a maximum of 20 investigational centers located in the United States an...
What is the current status of trial NCT00763698?
This trial is currently completed. It is a NA study. The enrollment target is 86 participants. The study started on 2008-10. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00763698?
The interventions under investigation include: QuickFlex Micro Model 1258T Left Heart Lead (DEVICE).
Who is sponsoring clinical trial NCT00763698?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.